title: Ventricular arrhythmias: state of the art.
abstract: The management of ventricular tachycardia and ventricular fibrillation in the cardiac intensive care unit can be complex. These arrhythmias have many triggers, including ischemia, sympathetic stimulation, and medication toxicities, as well as many different substrates, ranging from ischemic and nonischemic cardiomyopathies to rare genetic conditions such as Brugada syndrome and long QT syndrome. Different settings, such as congenital heart disease, postoperative ventricular arrhythmias, and ventricular assist devices, increase the complexity of management. This article reviews the variety of situations and cardiac conditions that give rise to ventricular arrhythmias, focusing on inpatient management strategies.
authors.affiliation: Division of Cardiovascular Diseases, Mayo Clinic Arizona, 13400 East Shea Boulevard, Scottsdale, AZ 85259, USA.
authors.forename: J William
authors.initials: JW
authors.lastname: Schleifer
authors.forename: Komandoor
authors.initials: K
authors.lastname: Srivathsan
mesh_terms: D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D002304:Cardiac Pacing, Artificial / Q000379:methods; D009202:Cardiomyopathies / Q000150:complications; D017115:Catheter Ablation; D004562:Electrocardiography; D006330:Heart Defects, Congenital / Q000150:complications; D016027:Heart Transplantation; D006353:Heart-Assist Devices; D006801:Humans; D011182:Postoperative Care / Q000379:methods; D055502:Secondary Prevention; D017180:Tachycardia, Ventricular / Q000175:diagnosis / Q000628:therapy; D014693:Ventricular Fibrillation / Q000175:diagnosis / Q000628:therapy*
chemical_list: D000889:Anti-Arrhythmia Agents
keywords: Antiarrhythmic medications; Catheter ablation; Electrical storm; Ventricular fibrillation; Ventricular tachycardia